Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma
Open Access
- 28 August 2019
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-11
Abstract
Recent studies reported that blood-based microRNAs (miRNAs) could detect cancers and predict prognosis have opened a new field of utilizing circulating miRNAs as cancer biomarkers. In this pilot study, we conducted for the first time, to our knowledge, the evaluation of the applicability of salivary miRNAs as novel biomarkers for nasopharyngeal carcinoma (NPC) detection. Microarray miRNA expression profiling was performed on saliva samples from 22 newly diagnosed NPC patients and 25 healthy controls, and 12 significantly down-regulated miRNAs were selected for quantitative real-time-PCR (qRT-PCR) validation and further analysis. Their target genes enriched by gene ontology and pathway analysis were used to construct regulatory and interaction networks. The receiver operating characteristic analyses (ROC) and logistic regression were calculated to assess discriminatory accuracy. Twelve dysregulated miRNAs screened by microarray that showed the same expression patterns with qRT-PCR analysis. Through bioinformatics analysis, the most prominent hub gene probably regulated by the 12 down-regulated miRNAs is found to be TP53. The ROC including the 12 miRNAs separated NPC patients from healthy controls with very high accuracy (areas under the receiver operating characteristic curve [AUC] = 0.999, sensitivity = 100.00%, specificity = 96.00%). Furthermore, if only six significantly dysregulated miRNAs were selected for the ROC analysis, the accuracy is still impressive (AUC = 0.941, sensitivity = 95.45%, specificity = 80.00%). This study highlights the potential for salivary miRNAs as biomarkers for the detection of NPC. Meanwhile, differentially expressed miRNAs in saliva might play critical roles in NPC by regulating their target genes, which associated with some significant pathways, such as p53 signaling pathway.Keywords
Funding Information
- National Natural Science Foundation of China (61671445, 81672989)
- Excellent Young Scientists Fund (31300301)
- Jiangsu Provincial Commission of Health and Family Planning (Q201601)
- Science and Technology Support Program of Jiangsu Province (BE2016681)
This publication has 28 references indexed in Scilit:
- Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal CancerPLOS ONE, 2013
- Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal CarcinomaPLOS ONE, 2012
- Introduction to the Role of MicroRNAs in Cancer Diagnosis, Prognosis, and TreatmentThe Cancer Journal, 2012
- Label-free high-throughput microRNA expression profiling from total RNANucleic Acids Research, 2011
- MicroRNAs in Development and DiseasePhysiological Reviews, 2011
- Diagnostic Potential of Saliva: Current State and Future ApplicationsClinical Chemistry, 2011
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProceedings of the National Academy of Sciences, 2011
- The MicroRNA Spectrum in 12 Body FluidsClinical Chemistry, 2010
- MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteinsProceedings of the National Academy of Sciences, 2008
- MicroRNAsCell, 2004